Evidence map›Paper›PMID 41940384›Full record

ArticlePeerJ2026

Synthesis and hypoglycemic efficacy assessment of epigallocatechin gallate-selenium nanoparticles (EGCG-Se NPs) nanocomposites.

Huiqing Ma, Lijia Sun, Huaibo Yuan, Wenhong Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huiqing MaSchool of Biological and Food Engineering, Hefei University of Technology, Anhui, Hefei, China.
Lijia SunSchool of Biological and Food Engineering, Hefei University of Technology, Anhui, Hefei, China.
Huaibo YuanSchool of Biological and Food Engineering, Hefei University of Technology, Anhui, Hefei, China.
Wenhong LiuSchool of Chemistry and Chemical Engineering, Hefei University of Technology, Anhui, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of Selenium nanoparticles (Se NPs) using plant extracts has been widely recognized for many advantages. In this study, Epigallocatechin gallate (EGCG) was used as the reducing agent for sodium selenite to obtain Epigallocatechin gallate-Selenium nanoparticles (EGCG-Se NPs) whose hypoglycemic potential was evaluated. The Ultraviolet-visible(UV-Vis) spectra, Fourier Transform Infrared Spectroscopy (FTIR) profiles, and X-ray Photoelectron Spectroscopy (XPS) analysis of EGCG-Se NPs all confirmed the Se-O coordination bonds between Se NPs and EGCG, which is conducive to improving the stability of the molecular structure of the complex. The ellipsoidal structure (20-90 nm) and amorphous state of EGCG-Se NPs were characterized

Indexed as

CatechinHypoglycemic AgentsNanocompositesNanoparticlesSeleniumAnimalsSpectroscopy, Fourier Transform InfraredX-Ray DiffractionCatechinepigallocatechin gallateHypoglycemic AgentsSeleniumEpigallocatechin gallateHypoglycemiaSelenium nanoparticlesα-Amylaseα-Glucosidase

Identifiers

PMID41940384
PMCPMC13045847

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.